HSBC cuts biotech stocks: Eli Lilly lowered to Reduce
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Wall Street sinks as bond yields rise, Walmart results disappoint
GSK Q1 earnings preview: 'Vaccines remain a drag' – Barclays
April 29, 2025 4:00 PM EDTBarclays told investors in a note Tuesday that it expects GSK's (NYSE: GSK) first-quarter 2025 results to be weighed down by continued weakness in its vaccines segment, but believes the rest of the portfolio will provide enough support to meet consensus expectations.
Vaccines remain a drag, the analysts wrote, citing ongoing declines in prescriptions for both Shingrix and Arexvy in the U.S.
Barclays trimmed its forecasts for these key vaccines ahead of earnings,... More
